Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0M6OW
|
||||
| Former ID |
DPR000170
|
||||
| Drug Name |
ANAVEX 1007
|
||||
| Indication | Melanoma; Prostate cancer; Pancreatic cancer [ICD9: 140-229, 157, 172, 185; ICD10:C25, C43, C61] | Preclinical | [1] | ||
| Company |
Anavex
|
||||
| Target and Pathway | |||||
| Target(s) | Sigma 2-type opioid receptor | Target Info | Agonist | [1] | |
| Sigma(1)-type opioid receptor | Target Info | Agonist | [1] | ||
| WikiPathways | miR-targeted genes in squamous cell - TarBase | ||||
| miR-targeted genes in lymphocytes - TarBase | |||||
| References | |||||
| REF 1 | 2011 Pipeline of Anavex. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.